nodes	percent_of_prediction	percent_of_DWPC	metapath
Flumazenil—Hypersensitivity—Chlorambucil—testicular cancer	0.00318	0.00318	CcSEcCtD
Flumazenil—Thrombophlebitis—Methotrexate—testicular cancer	0.00318	0.00318	CcSEcCtD
Flumazenil—Hypoaesthesia—Etoposide—testicular cancer	0.00316	0.00316	CcSEcCtD
Flumazenil—Malaise—Ifosfamide—testicular cancer	0.00316	0.00316	CcSEcCtD
Flumazenil—Vertigo—Ifosfamide—testicular cancer	0.00315	0.00315	CcSEcCtD
Flumazenil—Hypotension—Bleomycin—testicular cancer	0.00313	0.00313	CcSEcCtD
Flumazenil—Asthenia—Chlorambucil—testicular cancer	0.0031	0.0031	CcSEcCtD
Flumazenil—Arrhythmia—Cisplatin—testicular cancer	0.0031	0.0031	CcSEcCtD
Flumazenil—Palpitations—Ifosfamide—testicular cancer	0.0031	0.0031	CcSEcCtD
Flumazenil—Abnormal vision—Epirubicin—testicular cancer	0.00309	0.00309	CcSEcCtD
Flumazenil—Pruritus—Chlorambucil—testicular cancer	0.00306	0.00306	CcSEcCtD
Flumazenil—Cough—Ifosfamide—testicular cancer	0.00306	0.00306	CcSEcCtD
Flumazenil—Hypertension—Ifosfamide—testicular cancer	0.00302	0.00302	CcSEcCtD
Flumazenil—Erythema—Cisplatin—testicular cancer	0.00302	0.00302	CcSEcCtD
Flumazenil—Paraesthesia—Bleomycin—testicular cancer	0.003	0.003	CcSEcCtD
Flumazenil—Dyspnoea—Bleomycin—testicular cancer	0.00298	0.00298	CcSEcCtD
Flumazenil—Chest pain—Ifosfamide—testicular cancer	0.00298	0.00298	CcSEcCtD
Flumazenil—Thrombophlebitis—Epirubicin—testicular cancer	0.00298	0.00298	CcSEcCtD
Flumazenil—Flushing—Etoposide—testicular cancer	0.00295	0.00295	CcSEcCtD
Flumazenil—Discomfort—Ifosfamide—testicular cancer	0.00295	0.00295	CcSEcCtD
Flumazenil—Hypersensitivity—Vinblastine—testicular cancer	0.00292	0.00292	CcSEcCtD
Flumazenil—Confusional state—Ifosfamide—testicular cancer	0.00288	0.00288	CcSEcCtD
Flumazenil—Abnormal vision—Doxorubicin—testicular cancer	0.00286	0.00286	CcSEcCtD
Flumazenil—Pain—Bleomycin—testicular cancer	0.00286	0.00286	CcSEcCtD
Flumazenil—Chills—Etoposide—testicular cancer	0.00285	0.00285	CcSEcCtD
Flumazenil—Vision blurred—Cisplatin—testicular cancer	0.00285	0.00285	CcSEcCtD
Flumazenil—Asthenia—Vinblastine—testicular cancer	0.00284	0.00284	CcSEcCtD
Flumazenil—Tremor—Cisplatin—testicular cancer	0.00283	0.00283	CcSEcCtD
Flumazenil—Ill-defined disorder—Cisplatin—testicular cancer	0.0028	0.0028	CcSEcCtD
Flumazenil—Hyperhidrosis—Ifosfamide—testicular cancer	0.00276	0.00276	CcSEcCtD
Flumazenil—Feeling abnormal—Bleomycin—testicular cancer	0.00276	0.00276	CcSEcCtD
Flumazenil—Hot flush—Epirubicin—testicular cancer	0.00275	0.00275	CcSEcCtD
Flumazenil—Thrombophlebitis—Doxorubicin—testicular cancer	0.00275	0.00275	CcSEcCtD
Flumazenil—Vomiting—Chlorambucil—testicular cancer	0.00275	0.00275	CcSEcCtD
Flumazenil—Menopausal symptoms—Epirubicin—testicular cancer	0.00273	0.00273	CcSEcCtD
Flumazenil—Malaise—Cisplatin—testicular cancer	0.00272	0.00272	CcSEcCtD
Flumazenil—Fatigue—Dactinomycin—testicular cancer	0.00269	0.00269	CcSEcCtD
Flumazenil—Hypotension—Ifosfamide—testicular cancer	0.00267	0.00267	CcSEcCtD
Flumazenil—Pain—Dactinomycin—testicular cancer	0.00267	0.00267	CcSEcCtD
Flumazenil—Urticaria—Bleomycin—testicular cancer	0.00266	0.00266	CcSEcCtD
Flumazenil—Dizziness—Vinblastine—testicular cancer	0.00262	0.00262	CcSEcCtD
Flumazenil—Mood swings—Methotrexate—testicular cancer	0.00261	0.00261	CcSEcCtD
Flumazenil—Ataxia—Methotrexate—testicular cancer	0.00259	0.00259	CcSEcCtD
Flumazenil—Diplopia—Epirubicin—testicular cancer	0.00258	0.00258	CcSEcCtD
Flumazenil—Feeling abnormal—Dactinomycin—testicular cancer	0.00257	0.00257	CcSEcCtD
Flumazenil—Nausea—Chlorambucil—testicular cancer	0.00257	0.00257	CcSEcCtD
Flumazenil—Paraesthesia—Ifosfamide—testicular cancer	0.00257	0.00257	CcSEcCtD
Flumazenil—Ill-defined disorder—Etoposide—testicular cancer	0.00257	0.00257	CcSEcCtD
Flumazenil—Anxiety—Cisplatin—testicular cancer	0.00256	0.00256	CcSEcCtD
Flumazenil—Dyspnoea—Ifosfamide—testicular cancer	0.00255	0.00255	CcSEcCtD
Flumazenil—Hot flush—Doxorubicin—testicular cancer	0.00255	0.00255	CcSEcCtD
Flumazenil—Somnolence—Ifosfamide—testicular cancer	0.00254	0.00254	CcSEcCtD
Flumazenil—Discomfort—Cisplatin—testicular cancer	0.00254	0.00254	CcSEcCtD
Flumazenil—Affect lability—Epirubicin—testicular cancer	0.00254	0.00254	CcSEcCtD
Flumazenil—Menopausal symptoms—Doxorubicin—testicular cancer	0.00253	0.00253	CcSEcCtD
Flumazenil—Vomiting—Vinblastine—testicular cancer	0.00252	0.00252	CcSEcCtD
Flumazenil—Malaise—Etoposide—testicular cancer	0.0025	0.0025	CcSEcCtD
Flumazenil—Vertigo—Etoposide—testicular cancer	0.00249	0.00249	CcSEcCtD
Flumazenil—Headache—Vinblastine—testicular cancer	0.00248	0.00248	CcSEcCtD
Flumazenil—Fatigue—Ifosfamide—testicular cancer	0.00247	0.00247	CcSEcCtD
Flumazenil—Hypersensitivity—Bleomycin—testicular cancer	0.00247	0.00247	CcSEcCtD
Flumazenil—Pain—Ifosfamide—testicular cancer	0.00245	0.00245	CcSEcCtD
Flumazenil—Mood swings—Epirubicin—testicular cancer	0.00244	0.00244	CcSEcCtD
Flumazenil—Ataxia—Epirubicin—testicular cancer	0.00242	0.00242	CcSEcCtD
Flumazenil—Cough—Etoposide—testicular cancer	0.00241	0.00241	CcSEcCtD
Flumazenil—Tachycardia—Cisplatin—testicular cancer	0.00241	0.00241	CcSEcCtD
Flumazenil—Asthenia—Bleomycin—testicular cancer	0.0024	0.0024	CcSEcCtD
Flumazenil—Hypertension—Etoposide—testicular cancer	0.00239	0.00239	CcSEcCtD
Flumazenil—Diplopia—Doxorubicin—testicular cancer	0.00238	0.00238	CcSEcCtD
Flumazenil—Hyperhidrosis—Cisplatin—testicular cancer	0.00238	0.00238	CcSEcCtD
Flumazenil—Pruritus—Bleomycin—testicular cancer	0.00237	0.00237	CcSEcCtD
Flumazenil—Feeling abnormal—Ifosfamide—testicular cancer	0.00236	0.00236	CcSEcCtD
Flumazenil—Chest pain—Etoposide—testicular cancer	0.00236	0.00236	CcSEcCtD
Flumazenil—Nausea—Vinblastine—testicular cancer	0.00235	0.00235	CcSEcCtD
Flumazenil—Affect lability—Doxorubicin—testicular cancer	0.00235	0.00235	CcSEcCtD
Flumazenil—Discomfort—Etoposide—testicular cancer	0.00233	0.00233	CcSEcCtD
Flumazenil—Hypotension—Cisplatin—testicular cancer	0.0023	0.0023	CcSEcCtD
Flumazenil—Hypersensitivity—Dactinomycin—testicular cancer	0.0023	0.0023	CcSEcCtD
Flumazenil—Confusional state—Etoposide—testicular cancer	0.00228	0.00228	CcSEcCtD
Flumazenil—Urticaria—Ifosfamide—testicular cancer	0.00227	0.00227	CcSEcCtD
Flumazenil—Mood swings—Doxorubicin—testicular cancer	0.00226	0.00226	CcSEcCtD
Flumazenil—Ataxia—Doxorubicin—testicular cancer	0.00224	0.00224	CcSEcCtD
Flumazenil—Asthenia—Dactinomycin—testicular cancer	0.00224	0.00224	CcSEcCtD
Flumazenil—Paraesthesia—Cisplatin—testicular cancer	0.00221	0.00221	CcSEcCtD
Flumazenil—Tachycardia—Etoposide—testicular cancer	0.0022	0.0022	CcSEcCtD
Flumazenil—Dyspnoea—Cisplatin—testicular cancer	0.0022	0.0022	CcSEcCtD
Flumazenil—Hyperhidrosis—Etoposide—testicular cancer	0.00218	0.00218	CcSEcCtD
Flumazenil—Vomiting—Bleomycin—testicular cancer	0.00213	0.00213	CcSEcCtD
Flumazenil—Drowsiness—Methotrexate—testicular cancer	0.00212	0.00212	CcSEcCtD
Flumazenil—Hypotension—Etoposide—testicular cancer	0.00211	0.00211	CcSEcCtD
Flumazenil—Rash—Bleomycin—testicular cancer	0.00211	0.00211	CcSEcCtD
Flumazenil—Pain—Cisplatin—testicular cancer	0.00211	0.00211	CcSEcCtD
Flumazenil—Dermatitis—Bleomycin—testicular cancer	0.00211	0.00211	CcSEcCtD
Flumazenil—Hypersensitivity—Ifosfamide—testicular cancer	0.00211	0.00211	CcSEcCtD
Flumazenil—Asthenia—Ifosfamide—testicular cancer	0.00205	0.00205	CcSEcCtD
Flumazenil—Sweating—Methotrexate—testicular cancer	0.00203	0.00203	CcSEcCtD
Flumazenil—Feeling abnormal—Cisplatin—testicular cancer	0.00203	0.00203	CcSEcCtD
Flumazenil—Paraesthesia—Etoposide—testicular cancer	0.00203	0.00203	CcSEcCtD
Flumazenil—Pruritus—Ifosfamide—testicular cancer	0.00202	0.00202	CcSEcCtD
Flumazenil—Dyspnoea—Etoposide—testicular cancer	0.00201	0.00201	CcSEcCtD
Flumazenil—Somnolence—Etoposide—testicular cancer	0.00201	0.00201	CcSEcCtD
Flumazenil—Nausea—Bleomycin—testicular cancer	0.00199	0.00199	CcSEcCtD
Flumazenil—Drowsiness—Epirubicin—testicular cancer	0.00198	0.00198	CcSEcCtD
Flumazenil—Vomiting—Dactinomycin—testicular cancer	0.00198	0.00198	CcSEcCtD
Flumazenil—Rash—Dactinomycin—testicular cancer	0.00197	0.00197	CcSEcCtD
Flumazenil—Fatigue—Etoposide—testicular cancer	0.00195	0.00195	CcSEcCtD
Flumazenil—Pain—Etoposide—testicular cancer	0.00193	0.00193	CcSEcCtD
Flumazenil—Sweating—Epirubicin—testicular cancer	0.0019	0.0019	CcSEcCtD
Flumazenil—Dizziness—Ifosfamide—testicular cancer	0.00189	0.00189	CcSEcCtD
Flumazenil—Feeling abnormal—Etoposide—testicular cancer	0.00186	0.00186	CcSEcCtD
Flumazenil—Nausea—Dactinomycin—testicular cancer	0.00185	0.00185	CcSEcCtD
Flumazenil—Drowsiness—Doxorubicin—testicular cancer	0.00184	0.00184	CcSEcCtD
Flumazenil—Visual impairment—Methotrexate—testicular cancer	0.00183	0.00183	CcSEcCtD
Flumazenil—Vomiting—Ifosfamide—testicular cancer	0.00182	0.00182	CcSEcCtD
Flumazenil—Hypersensitivity—Cisplatin—testicular cancer	0.00182	0.00182	CcSEcCtD
Flumazenil—Bradycardia—Epirubicin—testicular cancer	0.00181	0.00181	CcSEcCtD
Flumazenil—Rash—Ifosfamide—testicular cancer	0.0018	0.0018	CcSEcCtD
Flumazenil—Dermatitis—Ifosfamide—testicular cancer	0.0018	0.0018	CcSEcCtD
Flumazenil—Urticaria—Etoposide—testicular cancer	0.00179	0.00179	CcSEcCtD
Flumazenil—Tinnitus—Methotrexate—testicular cancer	0.00178	0.00178	CcSEcCtD
Flumazenil—Hypoaesthesia—Epirubicin—testicular cancer	0.00177	0.00177	CcSEcCtD
Flumazenil—Asthenia—Cisplatin—testicular cancer	0.00177	0.00177	CcSEcCtD
Flumazenil—Sweating—Doxorubicin—testicular cancer	0.00176	0.00176	CcSEcCtD
Flumazenil—Visual impairment—Epirubicin—testicular cancer	0.00172	0.00172	CcSEcCtD
Flumazenil—Chills—Methotrexate—testicular cancer	0.00171	0.00171	CcSEcCtD
Flumazenil—Nausea—Ifosfamide—testicular cancer	0.0017	0.0017	CcSEcCtD
Flumazenil—Bradycardia—Doxorubicin—testicular cancer	0.00168	0.00168	CcSEcCtD
Flumazenil—Hypersensitivity—Etoposide—testicular cancer	0.00166	0.00166	CcSEcCtD
Flumazenil—Tinnitus—Epirubicin—testicular cancer	0.00166	0.00166	CcSEcCtD
Flumazenil—Erythema—Methotrexate—testicular cancer	0.00166	0.00166	CcSEcCtD
Flumazenil—Flushing—Epirubicin—testicular cancer	0.00165	0.00165	CcSEcCtD
Flumazenil—Hypoaesthesia—Doxorubicin—testicular cancer	0.00164	0.00164	CcSEcCtD
Flumazenil—Asthenia—Etoposide—testicular cancer	0.00162	0.00162	CcSEcCtD
Flumazenil—Chills—Epirubicin—testicular cancer	0.0016	0.0016	CcSEcCtD
Flumazenil—Pruritus—Etoposide—testicular cancer	0.0016	0.0016	CcSEcCtD
Flumazenil—Arrhythmia—Epirubicin—testicular cancer	0.00159	0.00159	CcSEcCtD
Flumazenil—Visual impairment—Doxorubicin—testicular cancer	0.00159	0.00159	CcSEcCtD
Flumazenil—Vomiting—Cisplatin—testicular cancer	0.00157	0.00157	CcSEcCtD
Flumazenil—Vision blurred—Methotrexate—testicular cancer	0.00156	0.00156	CcSEcCtD
Flumazenil—Rash—Cisplatin—testicular cancer	0.00155	0.00155	CcSEcCtD
Flumazenil—Dermatitis—Cisplatin—testicular cancer	0.00155	0.00155	CcSEcCtD
Flumazenil—Erythema—Epirubicin—testicular cancer	0.00155	0.00155	CcSEcCtD
Flumazenil—Ill-defined disorder—Methotrexate—testicular cancer	0.00154	0.00154	CcSEcCtD
Flumazenil—Tinnitus—Doxorubicin—testicular cancer	0.00154	0.00154	CcSEcCtD
Flumazenil—Flushing—Doxorubicin—testicular cancer	0.00153	0.00153	CcSEcCtD
Flumazenil—Tension—Epirubicin—testicular cancer	0.00152	0.00152	CcSEcCtD
Flumazenil—Nervousness—Epirubicin—testicular cancer	0.00151	0.00151	CcSEcCtD
Flumazenil—Malaise—Methotrexate—testicular cancer	0.00149	0.00149	CcSEcCtD
Flumazenil—Dizziness—Etoposide—testicular cancer	0.00149	0.00149	CcSEcCtD
Flumazenil—Vertigo—Methotrexate—testicular cancer	0.00149	0.00149	CcSEcCtD
Flumazenil—Chills—Doxorubicin—testicular cancer	0.00148	0.00148	CcSEcCtD
Flumazenil—Arrhythmia—Doxorubicin—testicular cancer	0.00147	0.00147	CcSEcCtD
Flumazenil—Nausea—Cisplatin—testicular cancer	0.00146	0.00146	CcSEcCtD
Flumazenil—Vision blurred—Epirubicin—testicular cancer	0.00146	0.00146	CcSEcCtD
Flumazenil—Cough—Methotrexate—testicular cancer	0.00145	0.00145	CcSEcCtD
Flumazenil—Ill-defined disorder—Epirubicin—testicular cancer	0.00144	0.00144	CcSEcCtD
Flumazenil—Vomiting—Etoposide—testicular cancer	0.00144	0.00144	CcSEcCtD
Flumazenil—Erythema—Doxorubicin—testicular cancer	0.00144	0.00144	CcSEcCtD
Flumazenil—Agitation—Epirubicin—testicular cancer	0.00143	0.00143	CcSEcCtD
Flumazenil—Rash—Etoposide—testicular cancer	0.00142	0.00142	CcSEcCtD
Flumazenil—Dermatitis—Etoposide—testicular cancer	0.00142	0.00142	CcSEcCtD
Flumazenil—Headache—Etoposide—testicular cancer	0.00141	0.00141	CcSEcCtD
Flumazenil—Chest pain—Methotrexate—testicular cancer	0.00141	0.00141	CcSEcCtD
Flumazenil—Tension—Doxorubicin—testicular cancer	0.00141	0.00141	CcSEcCtD
Flumazenil—Malaise—Epirubicin—testicular cancer	0.0014	0.0014	CcSEcCtD
Flumazenil—Discomfort—Methotrexate—testicular cancer	0.00139	0.00139	CcSEcCtD
Flumazenil—Nervousness—Doxorubicin—testicular cancer	0.00139	0.00139	CcSEcCtD
Flumazenil—Vertigo—Epirubicin—testicular cancer	0.00139	0.00139	CcSEcCtD
Flumazenil—Palpitations—Epirubicin—testicular cancer	0.00137	0.00137	CcSEcCtD
Flumazenil—Confusional state—Methotrexate—testicular cancer	0.00136	0.00136	CcSEcCtD
Flumazenil—Cough—Epirubicin—testicular cancer	0.00135	0.00135	CcSEcCtD
Flumazenil—Vision blurred—Doxorubicin—testicular cancer	0.00135	0.00135	CcSEcCtD
Flumazenil—Nausea—Etoposide—testicular cancer	0.00134	0.00134	CcSEcCtD
Flumazenil—Hypertension—Epirubicin—testicular cancer	0.00134	0.00134	CcSEcCtD
Flumazenil—Ill-defined disorder—Doxorubicin—testicular cancer	0.00133	0.00133	CcSEcCtD
Flumazenil—Chest pain—Epirubicin—testicular cancer	0.00132	0.00132	CcSEcCtD
Flumazenil—Agitation—Doxorubicin—testicular cancer	0.00132	0.00132	CcSEcCtD
Flumazenil—Anxiety—Epirubicin—testicular cancer	0.00132	0.00132	CcSEcCtD
Flumazenil—Hyperhidrosis—Methotrexate—testicular cancer	0.00131	0.00131	CcSEcCtD
Flumazenil—Discomfort—Epirubicin—testicular cancer	0.0013	0.0013	CcSEcCtD
Flumazenil—Malaise—Doxorubicin—testicular cancer	0.00129	0.00129	CcSEcCtD
Flumazenil—Dry mouth—Epirubicin—testicular cancer	0.00129	0.00129	CcSEcCtD
Flumazenil—Vertigo—Doxorubicin—testicular cancer	0.00129	0.00129	CcSEcCtD
Flumazenil—Confusional state—Epirubicin—testicular cancer	0.00128	0.00128	CcSEcCtD
Flumazenil—Palpitations—Doxorubicin—testicular cancer	0.00127	0.00127	CcSEcCtD
Flumazenil—Hypotension—Methotrexate—testicular cancer	0.00126	0.00126	CcSEcCtD
Flumazenil—Cough—Doxorubicin—testicular cancer	0.00125	0.00125	CcSEcCtD
Flumazenil—Hypertension—Doxorubicin—testicular cancer	0.00124	0.00124	CcSEcCtD
Flumazenil—Tachycardia—Epirubicin—testicular cancer	0.00124	0.00124	CcSEcCtD
Flumazenil—Hyperhidrosis—Epirubicin—testicular cancer	0.00122	0.00122	CcSEcCtD
Flumazenil—Insomnia—Methotrexate—testicular cancer	0.00122	0.00122	CcSEcCtD
Flumazenil—Chest pain—Doxorubicin—testicular cancer	0.00122	0.00122	CcSEcCtD
Flumazenil—Anxiety—Doxorubicin—testicular cancer	0.00122	0.00122	CcSEcCtD
Flumazenil—Paraesthesia—Methotrexate—testicular cancer	0.00121	0.00121	CcSEcCtD
Flumazenil—Discomfort—Doxorubicin—testicular cancer	0.00121	0.00121	CcSEcCtD
Flumazenil—Dyspnoea—Methotrexate—testicular cancer	0.00121	0.00121	CcSEcCtD
Flumazenil—Somnolence—Methotrexate—testicular cancer	0.0012	0.0012	CcSEcCtD
Flumazenil—Dry mouth—Doxorubicin—testicular cancer	0.0012	0.0012	CcSEcCtD
Flumazenil—Hypotension—Epirubicin—testicular cancer	0.00118	0.00118	CcSEcCtD
Flumazenil—Confusional state—Doxorubicin—testicular cancer	0.00118	0.00118	CcSEcCtD
Flumazenil—Fatigue—Methotrexate—testicular cancer	0.00117	0.00117	CcSEcCtD
Flumazenil—Pain—Methotrexate—testicular cancer	0.00116	0.00116	CcSEcCtD
Flumazenil—Insomnia—Epirubicin—testicular cancer	0.00114	0.00114	CcSEcCtD
Flumazenil—Tachycardia—Doxorubicin—testicular cancer	0.00114	0.00114	CcSEcCtD
Flumazenil—Paraesthesia—Epirubicin—testicular cancer	0.00114	0.00114	CcSEcCtD
Flumazenil—Hyperhidrosis—Doxorubicin—testicular cancer	0.00113	0.00113	CcSEcCtD
Flumazenil—Dyspnoea—Epirubicin—testicular cancer	0.00113	0.00113	CcSEcCtD
Flumazenil—Somnolence—Epirubicin—testicular cancer	0.00113	0.00113	CcSEcCtD
Flumazenil—Feeling abnormal—Methotrexate—testicular cancer	0.00111	0.00111	CcSEcCtD
Flumazenil—Hypotension—Doxorubicin—testicular cancer	0.00109	0.00109	CcSEcCtD
Flumazenil—Fatigue—Epirubicin—testicular cancer	0.00109	0.00109	CcSEcCtD
Flumazenil—Pain—Epirubicin—testicular cancer	0.00108	0.00108	CcSEcCtD
Flumazenil—Urticaria—Methotrexate—testicular cancer	0.00107	0.00107	CcSEcCtD
Flumazenil—Insomnia—Doxorubicin—testicular cancer	0.00106	0.00106	CcSEcCtD
Flumazenil—Paraesthesia—Doxorubicin—testicular cancer	0.00105	0.00105	CcSEcCtD
Flumazenil—Dyspnoea—Doxorubicin—testicular cancer	0.00104	0.00104	CcSEcCtD
Flumazenil—Feeling abnormal—Epirubicin—testicular cancer	0.00104	0.00104	CcSEcCtD
Flumazenil—Somnolence—Doxorubicin—testicular cancer	0.00104	0.00104	CcSEcCtD
Flumazenil—Fatigue—Doxorubicin—testicular cancer	0.00101	0.00101	CcSEcCtD
Flumazenil—Urticaria—Epirubicin—testicular cancer	0.00101	0.00101	CcSEcCtD
Flumazenil—Pain—Doxorubicin—testicular cancer	0.001	0.001	CcSEcCtD
Flumazenil—Hypersensitivity—Methotrexate—testicular cancer	0.000997	0.000997	CcSEcCtD
Flumazenil—Asthenia—Methotrexate—testicular cancer	0.000971	0.000971	CcSEcCtD
Flumazenil—Feeling abnormal—Doxorubicin—testicular cancer	0.000965	0.000965	CcSEcCtD
Flumazenil—Pruritus—Methotrexate—testicular cancer	0.000957	0.000957	CcSEcCtD
Flumazenil—Hypersensitivity—Epirubicin—testicular cancer	0.000933	0.000933	CcSEcCtD
Flumazenil—Urticaria—Doxorubicin—testicular cancer	0.000931	0.000931	CcSEcCtD
Flumazenil—Asthenia—Epirubicin—testicular cancer	0.000908	0.000908	CcSEcCtD
Flumazenil—Pruritus—Epirubicin—testicular cancer	0.000896	0.000896	CcSEcCtD
Flumazenil—Dizziness—Methotrexate—testicular cancer	0.000895	0.000895	CcSEcCtD
Flumazenil—Hypersensitivity—Doxorubicin—testicular cancer	0.000863	0.000863	CcSEcCtD
Flumazenil—Vomiting—Methotrexate—testicular cancer	0.00086	0.00086	CcSEcCtD
Flumazenil—Rash—Methotrexate—testicular cancer	0.000853	0.000853	CcSEcCtD
Flumazenil—Dermatitis—Methotrexate—testicular cancer	0.000852	0.000852	CcSEcCtD
Flumazenil—Headache—Methotrexate—testicular cancer	0.000847	0.000847	CcSEcCtD
Flumazenil—Asthenia—Doxorubicin—testicular cancer	0.00084	0.00084	CcSEcCtD
Flumazenil—Dizziness—Epirubicin—testicular cancer	0.000837	0.000837	CcSEcCtD
Flumazenil—Pruritus—Doxorubicin—testicular cancer	0.000829	0.000829	CcSEcCtD
Flumazenil—Vomiting—Epirubicin—testicular cancer	0.000805	0.000805	CcSEcCtD
Flumazenil—Nausea—Methotrexate—testicular cancer	0.000804	0.000804	CcSEcCtD
Flumazenil—Rash—Epirubicin—testicular cancer	0.000798	0.000798	CcSEcCtD
Flumazenil—Dermatitis—Epirubicin—testicular cancer	0.000797	0.000797	CcSEcCtD
Flumazenil—Headache—Epirubicin—testicular cancer	0.000793	0.000793	CcSEcCtD
Flumazenil—Dizziness—Doxorubicin—testicular cancer	0.000775	0.000775	CcSEcCtD
Flumazenil—Nausea—Epirubicin—testicular cancer	0.000752	0.000752	CcSEcCtD
Flumazenil—Vomiting—Doxorubicin—testicular cancer	0.000745	0.000745	CcSEcCtD
Flumazenil—Rash—Doxorubicin—testicular cancer	0.000739	0.000739	CcSEcCtD
Flumazenil—Dermatitis—Doxorubicin—testicular cancer	0.000738	0.000738	CcSEcCtD
Flumazenil—Headache—Doxorubicin—testicular cancer	0.000734	0.000734	CcSEcCtD
Flumazenil—Nausea—Doxorubicin—testicular cancer	0.000696	0.000696	CcSEcCtD
